Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...
Jan 29 (Reuters) - Private equity firm KKR (KKR.N), opens new tab has taken a large stake in Henry Schein (HSIC.O), opens new tab and reached a deal to add members to the company's board ...
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation. Shares of the company fell ...
Q4 2024 Management View CEO Stanley Bergman highlighted the completion of the 2022-2024 BOLD+1 Strategic Plan, exceeding the target of generating 40% of worldwide operating income from high-growth, ...
As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...
KKR (KKR) has taken a large stake in Henry Schein (HSIC) and plans to announce a deal that includes increasing that stake to 12% with the option to buy up to 2.9% more in the future, The Wall ...
Henry Schein and KKR will collaborate on a range of value-creation opportunities. Henry Schein will issue new shares of common stock to funds affiliated with KKR for a $250 million investment ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...
Reports Q4 revenue $3.19B, consensus $3.25B. “Our fourth quarter financial results reflect relatively stable dental and medical end-markets. We ...